USMLE Step 1 Quiz: Vaccines And Immune Memory

What this quiz covers

This quiz focuses on Vaccines And Immune Memory, giving you a quick way to practice the rules, question types, and explanations that matter most for USMLE Step 1.

How to use this quiz

Try each quiz question before looking at the correct answer. Use the explanations to review missed ideas, then come back to similar questions until the pattern feels familiar.

Question 1

1. Herd immunity (correct answer)
2. Passive immunity from maternal antibodies
3. Innate resistance to the measles virus
4. Cross-protective immunity from other childhood vaccines

Explanation: Herd immunity (or community immunity) occurs when a large proportion of a community is immune to a disease, making the spread of the disease from person to person unlikely. This high level of immunity provides indirect protection to individuals who are not immune, such as infants too young to be vaccinated, or those with contraindications. At 9 months, maternal IgG antibodies have waned significantly and would not provide reliable protection.

Question 2

1. Inducing antibodies that prevent the germination of Clostridium tetani spores
2. Generating cytotoxic T-lymphocytes that eliminate the bacteria
3. Promoting macrophage phagocytosis of the bacteria at the wound site
4. Producing neutralizing antibodies against the tetanus neurotoxin (correct answer)

Explanation: The clinical manifestations of tetanus are caused by a potent neurotoxin (tetanospasmin) produced by Clostridium tetani, not by the bacterium itself. The tetanus vaccine contains a toxoid, which is an inactivated form of the toxin. The vaccine induces the production of neutralizing antibodies that bind to the circulating neurotoxin and prevent it from reaching its target in the central nervous system, thereby preventing the symptoms of tetanus.

Question 3

1. A longer lag phase before antibody production begins
2. A higher magnitude of antibody production, which is primarily IgG (correct answer)
3. A lower affinity of antibodies for the viral antigens
4. The requirement for de novo activation of naive B and T lymphocytes

Explanation: The anamnestic, or secondary, immune response is mediated by pre-existing memory lymphocytes. It is qualitatively and quantitatively different from a primary response. Key features include a shorter lag phase (faster response), a much higher peak level of antibody production, and a predominance of high-affinity IgG antibodies due to isotype switching and affinity maturation that occurred during the primary response. It relies on the activation of memory cells, not naive lymphocytes.

Question 4

1. Anaphylactic reaction to vaccine components
2. Development of an Arthus reaction at the injection site
3. Disseminated disease from the attenuated vaccine strains (correct answer)
4. Failure to produce any IgG antibodies

Explanation: Live attenuated vaccines contain weakened but viable pathogens. In immunocompetent individuals, the immune system, particularly cell-mediated immunity driven by T-cells, can easily control the replication of the attenuated organism. In a patient with SCID who lacks functional T-cells, the attenuated virus can replicate uncontrollably, leading to a severe, disseminated, and potentially fatal infection. While failure to produce antibodies is also expected, the immediate life-threatening risk is uncontrolled viral replication.

Question 5

1. Integration of the mRNA into the host cell's genomic DNA
2. Replication of the mRNA by a viral-encoded RNA polymerase
3. Translation of the mRNA into protein by host cell ribosomes (correct answer)
4. Direct binding of the mRNA to B-cell receptors to stimulate antibody production

Explanation: mRNA vaccines work by delivering an mRNA template to the host's own cells. The lipid nanoparticle facilitates entry into the cytoplasm, where the mRNA is translated by the host cell's ribosomes into the viral spike protein. This newly synthesized protein is then processed and presented by the host cell on both MHC class I and II molecules (after secretion and uptake by APCs), stimulating a robust adaptive immune response involving both CD8+ T-cells, CD4+ T-cells, and B-cells.

Question 6

1. It allows the polysaccharide to be presented on MHC class II molecules
2. It converts the immune response from T-cell dependent to T-cell independent
3. It engages T-cell help to promote class switching and memory B-cell formation (correct answer)
4. It facilitates direct activation of macrophages without T-cell involvement

Explanation: Infants under 2 years old mount a poor immune response to T-independent antigens like bacterial polysaccharides. By conjugating the polysaccharide to a protein carrier, the B-cell that binds the polysaccharide can internalize the entire complex and present peptides from the protein carrier on its MHC class II molecules. This allows for recognition by carrier-specific helper T-cells, which then provide co-stimulation to the B-cell. This T-cell help is crucial for inducing immunoglobulin class switching (to IgG), affinity maturation, and the formation of long-lived memory B-cells.

Question 7

1. Production of serum IgG antibodies
2. Generation of mucosal secretory IgA (correct answer)
3. Activation of memory B cells in the spleen
4. Induction of a T-cell independent response

Explanation: The oral poliovirus vaccine (OPV) contains a live attenuated virus that replicates in the gastrointestinal tract, the natural site of poliovirus infection. This local replication effectively stimulates the mucosal-associated lymphoid tissue (MALT) to produce secretory IgA, which provides mucosal immunity and helps prevent initial infection and shedding of the virus. The inactivated polio vaccine (IPV) is injected and primarily induces a systemic IgG response, which prevents viremia and paralytic disease but is less effective at inducing mucosal immunity.

Question 8

1. To act as a carrier protein for the pertussis antigens
2. To create an antigen depot and stimulate the innate immune system (correct answer)
3. To directly cross-link B-cell receptors to trigger class switching
4. To neutralize any residual toxicity of the pertussis antigens

Explanation: Adjuvants like aluminum salts are added to subunit and inactivated vaccines to enhance their immunogenicity. They function by creating a depot effect, slowly releasing the antigen over time, and, more importantly, by stimulating the innate immune system. They activate pattern recognition receptors, leading to local inflammation, recruitment of antigen-presenting cells (APCs), and upregulation of co-stimulatory molecules, which results in a more robust and durable adaptive immune response.

Question 9

1. Eosinophils releasing granules to destroy infected cells
2. CD8+ cytotoxic T-lymphocytes recognizing viral antigens on MHC class I (correct answer)
3. B-cells producing IgE that opsonizes virally infected cells
4. Th2 cells secreting IL-4 and IL-5 to promote a humoral response only

Explanation: Live viral vaccines, like MMR, lead to the infection of host cells. Viral proteins are synthesized within these cells and processed through the endogenous pathway, leading to the presentation of viral peptides on MHC class I molecules. This presentation activates virus-specific CD8+ T-cells, which differentiate into cytotoxic T-lymphocytes (CTLs). CTLs are essential for identifying and killing virally infected host cells, thereby clearing the infection and contributing to long-term immunity.

Question 10

1. To establish long-term active immunity
2. To provide immediate passive neutralization of the virus (correct answer)
3. To act as an adjuvant for the rabies vaccine
4. To accelerate the development of memory T-cells

Explanation: Rabies immune globulin (RIG) is a preparation of concentrated, pre-formed anti-rabies antibodies. Its purpose is to provide immediate, passive immunity by binding to and neutralizing the rabies virus before it can enter the central nervous system. This temporary protection bridges the gap until the patient's own immune system can generate a protective active immune response, stimulated by the concurrently administered rabies vaccine.

Question 11

1. They primarily stimulate a mucosal IgA response
2. The antigens they contain are cleared rapidly and induce less robust memory (correct answer)
3. They are more likely to cause reversion to a virulent form
4. They provide immunity by transferring pre-formed antibodies

Explanation: Inactivated or subunit vaccines contain non-replicating antigens. The immune system is exposed to a finite amount of antigen that is cleared relatively quickly. This generally leads to a less robust and less persistent immune response compared to live attenuated vaccines, which replicate in the host and provide a more sustained antigenic stimulus. Consequently, the memory B-cell and T-cell populations generated by inactivated vaccines may be smaller or wane more quickly over time, necessitating periodic booster doses to maintain protective immunity.

Question 12

1. Isotype switching
2. Somatic hypermutation (correct answer)
3. Clonal deletion
4. V(D)J recombination

Explanation: The increase in antigen-binding affinity of antibodies seen after repeated exposure to an antigen is known as affinity maturation. This process occurs within the germinal centers of secondary lymphoid organs and is driven by somatic hypermutation, where the variable-region genes of B-cells undergo a high rate of point mutations. B-cells whose receptors have mutated to have higher affinity for the antigen are then preferentially selected to survive and proliferate, leading to a population of B-cells and plasma cells that produce higher-affinity antibodies.

Question 13

1. Pre-existing natural killer cells
2. Antigen-specific memory B-cells (correct answer)
3. Naive T-cells in the thymus
4. Toll-like receptors on epithelial cells

Explanation: Vaccination against HPV generates long-lived, antigen-specific memory B-cells and memory T-cells. Upon subsequent exposure to HPV, these memory B-cells are rapidly activated. They quickly proliferate and differentiate into plasma cells, which produce large quantities of high-affinity neutralizing IgG antibodies. This swift and potent secondary antibody response prevents the virus from establishing an infection.

Question 14

1. Antigen-specific secretory IgA (correct answer)
2. Serum IgM antibodies
3. Memory CD4+ T-cells in the spleen
4. Systemic IgG4 antibodies

Explanation: Administering a live attenuated vaccine to a mucosal surface, such as the nasal epithelium, mimics the natural route of infection for many respiratory pathogens. This stimulates the local mucosal-associated lymphoid tissue (MALT), leading to the production of secretory IgA. Secretory IgA is crucial for mucosal immunity as it can neutralize pathogens at the site of entry, preventing them from infecting host cells. Intramuscular vaccines primarily induce a systemic IgG response.

Question 15

1. Transfer of maternal memory T-cells across the placenta
2. Passage of maternal IgG antibodies to the fetus (correct answer)
3. Secretion of maternal IgA into the breast milk
4. In utero activation of the fetal immune system by vaccine antigens

Explanation: Vaccinating a pregnant woman boosts her levels of antigen-specific IgG antibodies. IgG is the only immunoglobulin isotype that can actively be transported across the placenta into the fetal circulation. This provides the newborn with a high level of maternal IgG at birth, offering passive immunity against pathogens like Bordetella pertussis until the infant can receive its own primary vaccinations. While IgA is transferred via breast milk, the primary mechanism of protection from maternal Tdap vaccination is transplacental IgG.

Question 16

1. T helper 1 (Th1) cells
2. T helper 17 (Th17) cells
3. Regulatory T (Treg) cells
4. Follicular helper T (Tfh) cells (correct answer)

Explanation: Follicular helper T (Tfh) cells are a specialized subset of CD4+ helper T-cells that are critical for most T-cell dependent antibody responses. Tfh cells migrate into B-cell follicles and provide essential survival and activation signals to B-cells through CD40L-CD40 interactions and cytokine secretion (e.g., IL-21, IL-4). This Tfh cell help drives the formation of germinal centers, where B-cells undergo affinity maturation and isotype switching.

Question 17

1. MHC class I molecules, activating CD8+ T-cells (correct answer)
2. CD1 molecules, activating NKT cells
3. MHC class II molecules only, activating CD4+ T-cells
4. B-cell receptors, leading to a T-independent response

Explanation: Viral vector vaccines introduce genetic material into host cells, causing them to produce the foreign antigen endogenously (within the cell). Proteins synthesized in the cytoplasm are processed by the proteasome and loaded onto MHC class I molecules for presentation on the cell surface. This MHC class I presentation is the key pathway for activating antigen-specific CD8+ T-cells, which then differentiate into cytotoxic T-lymphocytes (CTLs) capable of killing infected cells.

Question 18

1. The vaccinia virus establishes a latent infection that provides non-specific immune stimulation
2. The viruses share conserved antigenic epitopes that are recognized by the same lymphocytes (correct answer)
3. The vaccinia vaccine contains an adjuvant that boosts the response to unrelated pathogens
4. The immune response to vaccinia upregulates toll-like receptors throughout the body

Explanation: Cross-protection occurs when the immune response generated against one pathogen is effective against another, related pathogen. This is possible because closely related organisms, such as different orthopoxviruses, often share conserved antigenic epitopes. Memory T-cells and B-cells generated in response to vaccination with vaccinia virus can recognize these shared epitopes on the monkeypox virus, leading to a rapid and effective secondary immune response that controls or prevents infection.

Question 19

1. A Type I IgE-mediated hypersensitivity reaction
2. Formation of immune complexes leading to a Type III hypersensitivity reaction
3. The adjuvant-mediated activation of the innate immune system (correct answer)
4. A delayed-type T-cell mediated hypersensitivity reaction

Explanation: Adjuvants are included in many non-live vaccines to boost immunogenicity. They work by activating the innate immune system at the site of injection. Adjuvants like aluminum salts are recognized by pattern recognition receptors on innate immune cells (macrophages, dendritic cells), triggering the release of pro-inflammatory cytokines and chemokines. This leads to the classic signs of local inflammation (pain, redness, swelling) and is an expected and necessary part of generating a strong adaptive immune response.

Question 20

1. Tetanus toxoid is a carbohydrate antigen, while measles is a protein antigen
2. The live vaccine's replication provides a broader and more sustained antigenic stimulus (correct answer)
3. Circulating anti-tetanus antibodies have a significantly shorter half-life
4. Clostridium tetani exhibits greater antigenic variation than the measles virus

Explanation: Live attenuated vaccines, like the measles vaccine, contain viruses that replicate within the host. This limited replication mimics a natural infection, providing a prolonged and diverse antigenic stimulus to the immune system. It effectively stimulates both humoral (B-cell) and cell-mediated (CD4+ and CD8+ T-cell) immunity, leading to the generation of a larger and more persistent pool of memory cells. In contrast, the tetanus toxoid is a non-replicating protein antigen that is cleared more quickly, resulting in a less robust and shorter-lived memory response that requires periodic boosting.